Your browser doesn't support javascript.
loading
TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progression.
Kälin, Roland E; Cai, Linzhi; Li, Yuping; Zhao, Dongxu; Zhang, Huabin; Cheng, Jiying; Zhang, Wenlong; Wu, Yingxi; Eisenhut, Katharina; Janssen, Philipp; Schmitt, Lukas; Enard, Wolfgang; Michels, Friederike; Flüh, Charlotte; Hou, Mengzhuo; Kirchleitner, Sabrina V; Siller, Sebastian; Schiemann, Matthias; Andrä, Immanuel; Montanez, Eloi; Giachino, Claudio; Taylor, Verdon; Synowitz, Michael; Tonn, Jörg-Christian; von Baumgarten, Louisa; Schulz, Christian; Hellmann, Ines; Glass, Rainer.
Afiliação
  • Kälin RE; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Cai L; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Li Y; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Zhao D; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Zhang H; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Cheng J; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Zhang W; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; Department of Neurology, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Wu Y; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Eisenhut K; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Janssen P; Anthropology and Human Genomics, Department Biology II, LMU Munich, 82152 Planegg-Martinsried, Germany.
  • Schmitt L; Anthropology and Human Genomics, Department Biology II, LMU Munich, 82152 Planegg-Martinsried, Germany.
  • Enard W; Anthropology and Human Genomics, Department Biology II, LMU Munich, 82152 Planegg-Martinsried, Germany.
  • Michels F; Department of Neurosurgery, University Hospital Center Schleswig Holstein, 24105 Kiel, Germany.
  • Flüh C; Department of Neurosurgery, University Hospital Center Schleswig Holstein, 24105 Kiel, Germany.
  • Hou M; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Kirchleitner SV; Department of Neurosurgery, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Siller S; Department of Neurosurgery, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Schiemann M; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 München, Germany.
  • Andrä I; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 München, Germany.
  • Montanez E; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona and Bellvitge Biomedical Research Institute (IDIBELL), 08907 Hospitalet de Llobregat, Spain.
  • Giachino C; Department of Biomedicine, University of Basel, 4058 Basel, Switzerland.
  • Taylor V; Department of Biomedicine, University of Basel, 4058 Basel, Switzerland.
  • Synowitz M; Department of Neurosurgery, University Hospital Center Schleswig Holstein, 24105 Kiel, Germany.
  • Tonn JC; Department of Neurosurgery, University Hospital, LMU Munich, 81377 Munich, Germany; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, 69120 Heidelberg, Germany.
  • von Baumgarten L; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; Department of Neurology, University Hospital, LMU Munich, 81377 Munich, Germany; Department of Neurosurgery, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Schulz C; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, 81377 Munich, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80333 Munich, Ge
  • Hellmann I; Anthropology and Human Genomics, Department Biology II, LMU Munich, 82152 Planegg-Martinsried, Germany.
  • Glass R; Neurosurgical Research, University Hospital, LMU Munich, 81377 Munich, Germany; Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, 69120 Heidelberg, German
Cell Syst ; 12(3): 248-262.e7, 2021 03 17.
Article em En | MEDLINE | ID: mdl-33592194
ABSTRACT
Aggressive brain tumors like glioblastoma depend on support by their local environment and subsets of tumor parenchymal cells may promote specific phases of disease progression. We investigated the glioblastoma microenvironment with transgenic lineage-tracing models, intravital imaging, single-cell transcriptomics, immunofluorescence analysis as well as histopathology and characterized a previously unacknowledged population of tumor-associated cells with a myeloid-like expression profile (TAMEP) that transiently appeared during glioblastoma growth. TAMEP of mice and humans were identified with specific markers. Notably, TAMEP did not derive from microglia or peripheral monocytes but were generated by a fraction of CNS-resident, SOX2-positive progenitors. Abrogation of this progenitor cell population, by conditional Sox2-knockout, drastically reduced glioblastoma vascularization and size. Hence, TAMEP emerge as a tumor parenchymal component with a strong impact on glioblastoma progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Células Mieloides Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Células Mieloides Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article